Eun-Joo Shin, Phil Ho Lee, Hyun Ji Kim, Toshitaka Nabeshima, Hyoung-Chun Kim
Index: J. Pharmacol. Sci. 106(1) , 22-7, (2008)
Full Text: HTML
Drug abuse involving dextromethorphan, an antitussive, has been a social problem in various geographic locations since the 1960s. Ironically, high doses of the drug confer neuroprotective activity with central nervous system and behavioral effects. Accumulating evidence suggests that metabolism to phencyclidine-like dextrorphan is not essential for the neuroprotective activity of dextromethorphan. Here, we review the neuroprotective properties of dextromethorphan and its potential for abuse and the potential neuroprotective effects of the drug's analogs and 3-hydroxymorphinan, a metabolite of dextromethorphan. These compounds may provide a novel therapeutic direction for the treatment of neurodegenerative diseases such as convulsive or parkinsonian-like disorders.
Structure | Name/CAS No. | Molecular Formula | Articles |
---|---|---|---|
![]() |
(+)-3-HYDROXYMORPHINAN HYDROBROMIDE
CAS:15676-23-0 |
C16H21NO |
A validated SIM GC/MS method for the simultaneous determinat...
2009-11-01 [Biomed. Chromatogr. 23(11) , 1131-7, (2009)] |
Simultaneous quantification of dextromethorphan and its meta...
2011-01-25 [J. Pharm. Biomed. Anal. 54(2) , 387-94, (2011)] |
Validation of a liquid chromatography-mass spectrometry meth...
2005-05-05 [J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 819(1) , 105-13, (2005)] |
New morphinan derivatives with negligible psychotropic effec...
2003-03-07 [Life Sci. 72(16) , 1883-95, (2003)] |
Metabolism of dextrorphan by CYP2D6 in different recombinant...
2009-02-01 [J. Pharm. Sci. 98(2) , 763-71, (2009)] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved